India Life Science Tools Market Assessment, By Type [Instruments, Consumables, Services], By Technology [Genomics, Proteomics, Cell Biology Technology, Lab Supplies, Others], By Product [Cell Culture Systems & 3D Cell Culture, Liquid Chromatography, Mass Spectrometry, Flow Cytometry, Cloning & Genome Engineering, Microscopy, Next Generation Sequencing, PCR & qPCR, Nucleic Acid Preparation, Nucleic Acid Microarray, Sanger Sequencing, Transfection Device & Gene Delivery Technologies, Nuclear Magnetic Resonance, Others], By End-user [Healthcare, Government & Academic Institutions, Biopharmaceutical Company, Industrial Applications, Others], By Region, Opportunities and Forecast, FY2017-FY2031F

India Life Science Tools market is estimated to grow at a CAGR of 11.2% between FY2024 and FY2031 to reach USD 33.76 billion in FY2031 from USD 14.44 billion in FY2023.

Home>Industry Reports>India Life Science Tools Market Assessment, Opportunities and Forecast, FY2017-FY2031F

India Life Science Tools market is estimated to grow at a CAGR of 11.2% between FY2024 and FY2031 to reach USD 33.76 billion in FY2031 from USD 14.44 billion in FY2023. The life sciences tools market in India is experiencing significant growth and innovation driven by various factors. With a rapidly expanding healthcare sector and a growing focus on research and development, the demand for advanced tools and technologies is on the rise. 

The life sciences sector is experiencing a significant boost due to a rise in government initiatives that aim to promote its growth. Notable among these initiatives are the "Make in India" campaign and the "National Medical Device Policy 2023." Additionally, the establishment of biotechnology and medical device parks, along with increased funding for research institutions, has attracted investments and fostered a culture of innovation within the sector. These government-led efforts are playing a vital role in driving the market forward. India is witnessing a surge in genomics research and its application in healthcare, including genetic testing, biomarker discovery, and precision medicine. This has led to the adoption of cutting-edge life sciences tools such as next-generation sequencing (NGS) platforms, genotyping arrays, and bioinformatics solutions. The pharmaceutical and biotechnology industry in India is also contributing to the growth of the life sciences tools market. With India being a global hub for pharmaceutical manufacturing, the demand for tools and technologies for drug discovery, development, and quality control is increasing.

Rapid Growth of Polymerase Chain Reaction (PCR) Technique

The Polymerase Chain Reaction (PCR) technique has indeed experienced rapid growth in the life science tools market in India. PCR technology has witnessed significant advancements, leading to improved accuracy, sensitivity, and speed. Novel PCR platforms and instruments with enhanced features have been developed, making it easier for researchers and clinicians to perform PCR assays. There have been an increasing number of research activities taking place in genomics, proteomics, and personalized medicine and PCR plays a crucial role in these fields by enabling the detection and analysis of DNA and RNA molecules. Researchers and scientists rely on PCR for various applications, such as gene expression analysis, pathogen detection, and genetic profiling.

Cipla stated the commercialization of its real-time COVID-19 RT-PCR test kit in India in May 2022. ‘RT-Direct’ multiplex COVID-19 RT PCR test kit, will be made available through a partnership with Genes2Me Pvt Ltd. The RT Direct test protocol eliminates the need for RNA extraction, resulting in a quicker process that can provide results within 45 minutes.

Advancements in Genomics and Personalized Medicine

India is witnessing significant advancements in genomics and personalized medicine, which are revolutionizing the field of life sciences tools. The rapid progress in genomics research and the availability of cost-effective sequencing technologies have enabled large-scale genomic studies and personalized medicine initiatives. The integration of genomics into healthcare is driving the demand for advanced life sciences tools that are facilitating genetic testing, biomarker discovery, and the development of targeted therapies tailored to individual patients. Additionally, the emergence of data analytics, artificial intelligence (AI), and machine learning (ML) in genomics and personalized medicine is opening new possibilities for data interpretation, predictive modeling, and precision medicine applications. These advancements in genomics and personalized medicine are poised to transform healthcare delivery and offer innovative solutions for diagnosing, treating, and managing various diseases in the Indian population.

MedGenome, a genomics company, offers a diverse range of genetic testing services encompassing cancer diagnostics, preimplantation genetic diagnosis (PGD), and pharmacogenomics. In 2022, the company introduced a novel test named "MedGenome CancerSEEK." This cutting-edge test aims to aid individuals in the early detection of cancer by identifying early warning signs associated with the disease.

Rapid Growth in Pharmaceutical & Biotechnology

India has emerged as a global hub for pharmaceutical manufacturing, with a strong presence in generic drug production. The biotechnology sector is also expanding rapidly, with increasing investments in research and development, biopharmaceutical manufacturing, and clinical trials. This growth in pharmaceutical and biotechnology is fueling the need for advanced life sciences tools for drug discovery, development, quality control, and manufacturing processes. Indian companies are investing in state-of-the-art equipment such as high-performance liquid chromatography (HPLC) systems, mass spectrometers, sequencing platforms, and molecular biology tools to enhance their capabilities and meet the industry's evolving requirements. Additionally, the sector's focus on innovative drug development, biologics, and biosimilars is further driving the demand for specialized tools and technologies in areas such as genetic engineering, protein analysis, and cell culture systems. The growing pharmaceutical and biotechnology industry in India presents significant opportunities for the life sciences tools market, fostering innovation, research collaborations, and technological advancements.

Genomix, a genetic testing company, made its debut in India in 2022, introducing its comprehensive range of genetic testing services. The company provides an array of tests that encompass various aspects of genetics, such as assessing cancer predisposition, carrier status for genetic conditions, and pharmacogenetics testing.

Government Initiatives

The Indian government has introduced a range of initiatives. These include the renowned "Make in India" campaign, which serves to attract investments and encourage innovation. Furthermore, the establishment of biotechnology parks and research institutions across the country has been undertaken to create an environment conducive to the growth of the life science tools market. These initiatives collectively aim to promote the development of cutting-edge technologies, foster research and development, and facilitate a thriving ecosystem for the life sciences industry in India.

In May 2023, the cabinet announced the National Medical Device Policy. The aim of this policy is to support a well-organized expansion of the medical device industry in order to fulfill public health goals related to accessibility, affordability, quality, and innovation. The objective is for this sector to achieve its maximum capabilities by implementing strategies such as establishing a supportive environment for manufacturing and emphasizing innovation. Additionally, the policy aims to establish a strong and efficient regulatory framework to ensure smooth operations.

The government has established 9 biotech parks in Tamil Nadu, Telangana, Kerala, Karnataka, Uttar Pradesh, and Haryana. The Department of Biotechnology (DBT), which operates under the Ministry of Science and Technology, has set up biotechnology parks and incubators throughout the country with the aim of transforming research into viable products and services. These facilities offer essential infrastructure support to facilitate this process.

Impact of COVID-19

The life science tools market experienced a favorable impact due to the COVID-19 pandemic. The outbreak of the virus resulted in a higher prevalence of diseases, leading to a subsequent rise in research and development endeavors. The increased investment in drug discovery is projected to drive the growth of the separation technology segment. A notable instance is Cipla's announcement in May 2022, regarding the commercialization of its COVID-19 PCR kit in India. The real-time RT-PCR test kit has undergone validation by a center approved by the Indian Council of Medical Research (ICMR).

Separation technologies, such as immunoprecipitation, chromatographic techniques, automated purification systems, and others, play a crucial role in the diagnosis and treatment of COVID-19. For instance, a study published in the Indian Journal of Medical Research in 2021 examined the use of a rapid immunoassay-based chromatographic test for COVID-19 diagnosis in a tertiary care teaching hospital in northern India. The study's findings demonstrated that these immunoassay-based rapid chromatographic tests can contribute to the swift detection, isolation, and treatment of individuals affected by COVID-19.

India Life Science Tools Market: Report Scope

India Life Science Tools Market Assessment, Opportunities and Forecast, FY2017-FY2031F”, is a comprehensive report by Markets & Data, providing in-depth analysis and qualitative & quantitative assessment of the current state of the life science tools market, industry dynamics and challenges. The report includes market size, segmental shares, growth trends, COVID-19 impact, opportunities and forecast between 2023 and 2030. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.

 

Report Attribute

Details

Base Year of the Analysis

FY2023

Historical Period

FY2017-FY2022

Forecast Period

FY2024-FY2031

Projected Growth Rate

CAGR of 11.2% between FY2024 and FY2031

Revenue Forecast in FY2031

USD 33.76 billion

Units

Revenue in USD billion

Segments Covered

Type, Technology, Product, End-user, and Region

Regions Covered

North, South, East, West and Central

Key Companies Profiled

Abbott, BD (Becton, Dickinson and Company), Biomérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, Hologic, Inc., Qiagen, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Sysmex Corporation, Diasorin S.P.A, Mylab Discovery Solutions Private Limited, Biogenix Inc. Pvt. Ltd, Trivitron Healthcare, POCT Services Private Limited.

Customization Scope

15% free report customization with purchase

Pricing and Purchase Options

Avail the customized purchase options to fulfil your precise research needs

Delivery Format

PDF and Excel through email (subject to the license purchased)

 

In this report, India Life Science Tools Market has been segmented into the following categories: 

1.       By Type

1.1.   Instruments

1.2.   Consumables

1.3.   Services

2.       By Technology

2.1.   Genomics

2.2.   Proteomics

2.3.   Cell Biology Technology

2.4.   Lab Supplies

2.5.   Others

3.       By Product

3.1.   Cell Culture Systems & 3D Cell Culture

3.2.   Liquid Chromatography

3.3.   Mass Spectrometry

3.4.   Flow Cytometry

3.5.   Cloning & Genome Engineering

3.6.   Microscopy

3.7.   Next Generation Sequencing

3.8.   PCR & qPCR

3.9.   Nucleic Acid Preparation

3.10.                  Nucleic Acid Microarray

3.11.                  Sanger Sequencing

3.12.                  Transfection Devices & Gene Delivery Technologies

3.13.                  Nuclear Magnetic Resonance (NMR)

3.14.                  Others

4.       By End-user

4.1.   Healthcare

4.1.1.Hospitals

4.1.2.Clinics

4.1.3.Research Laboratories

4.1.4.Diagnostic Laboratories

4.1.5.Physician Office

4.1.6.Community Centres

4.2.   Government & Academic Institutions

4.3.   Biopharmaceutical Company

4.4.   Industrial Applications

4.5.   Others

5.       By Region

5.1.   North

5.2.   South

5.3.   East

5.4.   West and Central

Key Players Landscape and Outlook

The life science tool market in India is dominated by several key players who contribute to the industry's landscape. These companies offer a wide range of tools, technologies, and services to support research, diagnostics, and other applications in the life sciences sector. Several important participants are implementing strategic measures such as introducing new products, expanding facilities, engaging in collaborations, and engaging in mergers and acquisitions. These actions are playing a significant role in propelling the market's growth. In January 2022, Mylab Discovery Solutions Pvt. Ltd. introduced CoviSwift, a point-of-care testing solution for COVID-19. This development is anticipated to expand India's testing capacity from 3000 laboratories to 60,000 laboratories.

An instance of collaboration in the Indian life science tool market is the strategic partnership between Avesthagen and Wipro, an Indian IT and consulting firm in June 2022. This collaboration aims to jointly develop and bring to market next-generation sequencing panels in India.

Market Xcel’s reports answer the following questions:

• What is the current and future market size of the product/service in question globally or specific to different countries?

• How are the markets divided into different product/service segments and the market size and growth of each segment?

• What is the market potential of different product segments and their investment case?

• How are the markets predicted to develop in the future and what factors will drive or inhibit growth?

• What is the business environment and regulatory landscape specific to the product/service?

Key Players Operating in India Life Science Tool Market

·         Abbott Laboratories

·         Becton, Dickinson and Company

·         Biomérieux SA

·         Bio-Rad Laboratories, Inc.

·         Danaher Corporation

·         Hologic, Inc.

·         Qiagen GmbH

·         F. Hoffmann-La Roche Ltd.

·         Siemens Healthineers

·         Sysmex Corporation

·         Diasorin S.P.A

·         Mylab Discovery Solutions Private Limited

·         Biogenix Inc. Pvt. Ltd

·         Trivitron Healthcare

·         POCT Services Private Limited

If you can't find what you're searching for or have any custom requirements for India Life Science Tools Market, you may approach our team at info@marketsandata.com

Table of Contents

1.       Research Methodology

2.       Project Scope & Definitions

3.       Impact of COVID-19 on the India Life Science Tools Market

4.       Executive Summary

5.       India Life Science Tools Market Outlook, FY2017-FY2031F

5.1.    Market Size & Forecast

5.1.1.By Value

5.1.2.By Volume

5.2.    By Type

5.2.1.Instruments

5.2.2.Consumables

5.2.3.Services

5.3.    By Technology

5.3.1.Genomics

5.3.2.Proteomics

5.3.3.Cell Biology Technology

5.3.4.Lab Supplies

5.3.5.Others

5.4.    By Product

5.4.1.Cell Culture Systems & 3D Cell Culture

5.4.2.Liquid Chromatography

5.4.3.Mass Spectrometry

5.4.4.Flow Cytometry

5.4.5.Cloning & Genome Engineering

5.4.6.Microscopy

5.4.7.Next Generation Sequencing

5.4.8.PCR & qPCR

5.4.9.Nucleic Acid Preparation

5.4.10.    Nucleic Acid Microarray

5.4.11.    Sanger Sequencing

5.4.12.    Transfection Devices & Gene Delivery Technologies

5.4.13.    Nuclear Magnetic Resonance (NMR)

5.4.14.    Others

5.5.    By End-user

5.5.1.Healthcare

5.5.1.1.              Hospitals

5.5.1.2.              Clinics

5.5.1.3.              Research Laboratories

5.5.1.4.              Diagnostic Laboratories

5.5.1.5.              Physician Office

5.5.1.6.              Community Centres

5.5.2.Government & Academic Institutions

5.5.3.Biopharmaceutical Company

5.5.4.Industrial Applications

5.5.5.Others

5.6.    By Region

5.6.1.North

5.6.2.South

5.6.3.East

5.6.4.West and Central

5.7.    By Company Market Share (%), FY2023

6.       Market Mapping, FY2023

6.1.    By Type

6.2.    By Technology

6.3.    By End-user

6.4.    By Product

6.5.    By Region

7.       Macro Environment and Industry Structure

7.1.    Supply Demand Analysis

7.2.    Import Export Analysis – Volume and Value

7.3.    Supply/Value Chain Analysis

7.4.    PESTEL Analysis

7.4.1.Political Factors

7.4.2.Economic System

7.4.3.Social Implications

7.4.4.Technological Advancements

7.4.5.Environmental Impacts

7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)

7.5.    Porter’s Five Forces Analysis

7.5.1.Supplier Power

7.5.2.Buyer Power

7.5.3.Substitution Threat

7.5.4.Threat from New Entrant

7.5.5.Competitive Rivalry

8.       Market Dynamics

8.1.    Growth Drivers

8.2.    Growth Inhibitors (Challenges, Restraints)

9.       Regulatory Framework and Innovation

9.1.    Clinical Trials

9.2.    Patent Landscape

9.3.    Regulatory Approvals

9.4.    Innovations/Emerging Technologies

10.   Key Players Landscape

10.1.                     Competition Matrix of Top Five Market Leaders

10.2.                     Market Revenue Analysis of Top Five Market Leaders (in %, FY2023)

10.3.                     Mergers and Acquisitions/Joint Ventures (If Applicable)

10.4.                     SWOT Analysis (For Five Market Players)

10.5.                     Patent Analysis (If Applicable)

11.   Pricing Analysis

12.   Case Studies

13.   Key Players Outlook

13.1.                     Becton, Dickinson, and Company

13.1.1.    Company Details

13.1.2.    Key Management Personnel

13.1.3.    Products & Services

13.1.4.    Financials (As reported)

13.1.5.    Key Market Focus & Geographical Presence

13.1.6.    Recent Developments

13.2.                     Agilent Technologies Inc.

13.3.                     Illumina Inc.

13.4.                     Thermo Fisher Scientific Inc.

13.5.                     F. Hoffmann-La Roche Ltd

13.6.                     Bio-Rad Laboratories Inc.

13.7.                     Merck KGaA

13.8.                     GE Healthcare

13.9.                     Bruker Corporation

13.10.                  Qiagen NV

13.11.                  Danaher Corporation

13.12.                  Abbott Laboratories Inc.

13.13.                  Shimadzu Corporation

13.14.                  Hitachi, Ltd.

13.15.                  Oxford Instruments plc

13.16.                  Zeiss International

*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14.   Strategic Recommendations

15.   About Us & Disclaimer

List of Figure

Figure 01 : COVID-19 Market Impact (By %)
Figure 02: India Life Science Tools Market, By Value, In USD Billion, FY2017-2031F
Figure 03: India Life Science Tools Market, By Volume, In Units, FY2017-2031F
Figure 04: India Life Science Tools Market Share, By Type, By Value Share, In %, FY2017-2031F
Figure 05: India Life Science Tools Market Share, By Technology, By Value Share, In %, FY2017-2031F
Figure 06: India Life Science Tools Market Share, By Product, By Value Share, In %, FY2017-2031F
Figure 07: India Life Science Tools Market Share, By End-user, By Value Share, In %, FY2017-2031F
Figure 08: India Life Science Tools Market Share, By Region, By Value Share, In %, FY2017-2031F
Figure 09: India Life Science Tools Market Share, By Company Market Share (%), FY2023
Figure 10: By Type Map-Market Size (USD Billion, FY2023) & Growth Rate (%, FY2024E-2031F)
Figure 11: By Technology Map-Market Size (USD Billion, FY2023) & Growth Rate (%, FY2024E-2031F)
Figure 12: By Product Map-Market Size (USD Billion, FY2023) & Growth Rate (%, FY2024E-2031F)
Figure 13: By End-user Map-Market Size (USD Billion, FY2023) & Growth Rate (%, FY2024E-2031F)
Figure 14: By Region Map-Market Size (USD Billion, FY2023) & Growth Rate (%, FY2024E-2031F)
Figure 15: Number of Patent Filings, FY2017-2021
Figure 16: India Life Sciences Patent Filings, FY2017-2021
Figure 17: Company Revenue, in USD Million, FY2022

List of Table - India Life Science Tools Market 

Table 1. Pricing Analysis of Products from Key Players

Table 2. Competition Matrix of Top 5 Market Leaders

Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)

Table 4. About Us - Region and Countries Where We Have Executed Client Projects

Frequently Asked Questions

What is the market size and growth rate of the India Life Science Tools Market?

arrowup
Heart

Global Tyre Market Opportunities and Forecast, 2016-2030F

Global Tyre Market size was valued at USD 261.29 billion in 2022, which is expected to reach USD 425.81 billion in 2030 with a CAGR of 6.15% for the forecast period between 2023 and 2030. ....Read More

Published on

December 2023

6,950

Heart

Japan Artificial Intelligence Market Assessment, Opportunities, and Forecast, FY2017-FY2031F

Japan's Artificial Intelligence market has been witnessing notable progress. The Japan Artificial Intelligence market is estimated to achieve a value of USD 15.84 billion by the fiscal year 2031, showing substantial growth from USD 5.95 billion in FY....Read More

Published on

December 2023

3,300

Heart

Vietnam Commercial Vehicle Market Assessment, Opportunities and Forecast, 2016-2030F

Vietnam Commercial Vehicle Market size was valued at USD 3.07 billion in 2022 which is expected to reach USD 5.84 billion in 2030 with a CAGR of 8.37% for the forecast period between 2023 and 2030. ....Read More

Published on

December 2023

3,300

Heart

Japan Internet of Things Market Assessment, Opportunities and Forecast, FY2017-FY2031

Japan Internet of Things Market size is valued at USD 11.71 billion in FY2023, expected to reach USD 50.08 billion in FY2031 with a CAGR of 19.92% for the forecast period between FY2024 and FY2031.....Read More

Published on

December 2023

3,300

Purchase Options

USD ($)

arrowdown

i

2,000

i

3,300

i

4,500

i

7,000

Tired of Searching?

Looking for Customization?

Some other doubt?

Need insights from a cohort?

REACH US

    icon_Five
    17, Okhla Industrial Estate Phase 3 Rd, Okhla Phase III, Okhla Industrial Estate, New Delhi, Delhi 110020
    call_Two
    +91 11 42343567
    icon_Six
    info@marketsandata.com
icon_Seven
5741 Cleveland street, Suite 120, VA beach, VA, USA 23462
call_Three
+1 (757) 343-3258
icon_Eight
190 Middle Road, # 14-10 Fortune Centre, Singapore -188979